These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 28106668)

  • 1. Primidone inhibits TRPM3 and attenuates thermal nociception in vivo.
    Krügel U; Straub I; Beckmann H; Schaefer M
    Pain; 2017 May; 158(5):856-867. PubMed ID: 28106668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRPM3 is a nociceptor channel involved in the detection of noxious heat.
    Vriens J; Owsianik G; Hofmann T; Philipp SE; Stab J; Chen X; Benoit M; Xue F; Janssens A; Kerselaers S; Oberwinkler J; Vennekens R; Gudermann T; Nilius B; Voets T
    Neuron; 2011 May; 70(3):482-94. PubMed ID: 21555074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flavanones that selectively inhibit TRPM3 attenuate thermal nociception in vivo.
    Straub I; Krügel U; Mohr F; Teichert J; Rizun O; Konrad M; Oberwinkler J; Schaefer M
    Mol Pharmacol; 2013 Nov; 84(5):736-50. PubMed ID: 24006495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Citrus fruit and fabacea secondary metabolites potently and selectively block TRPM3.
    Straub I; Mohr F; Stab J; Konrad M; Philipp SE; Oberwinkler J; Schaefer M
    Br J Pharmacol; 2013 Apr; 168(8):1835-50. PubMed ID: 23190005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of transient receptor potential cation channel subfamily M member-3 in bladder afferents is involved in chronic pain in cyclophosphamide-induced cystitis.
    Zhao M; Liu L; Chen Z; Ding N; Wen J; Liu J; Ge N; Zhang X
    Pain; 2022 Nov; 163(11):2200-2212. PubMed ID: 35413036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRPM3 Channels Play Roles in Heat Hypersensitivity and Spontaneous Pain after Nerve Injury.
    Su S; Yudin Y; Kim N; Tao YX; Rohacs T
    J Neurosci; 2021 Mar; 41(11):2457-2474. PubMed ID: 33478988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional expression and pharmacological modulation of TRPM3 in human sensory neurons.
    Vangeel L; Benoit M; Miron Y; Miller PE; De Clercq K; Chaltin P; Verfaillie C; Vriens J; Voets T
    Br J Pharmacol; 2020 Jun; 177(12):2683-2695. PubMed ID: 31985045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Volatile anaesthetics inhibit the thermosensitive nociceptor ion channel transient receptor potential melastatin 3 (TRPM3).
    Kelemen B; Lisztes E; Vladár A; Hanyicska M; Almássy J; Oláh A; Szöllősi AG; Pénzes Z; Posta J; Voets T; Bíró T; Tóth BI
    Biochem Pharmacol; 2020 Apr; 174():113826. PubMed ID: 31987857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease-associated mutations in the human TRPM3 render the channel overactive via two distinct mechanisms.
    Zhao S; Yudin Y; Rohacs T
    Elife; 2020 Apr; 9():. PubMed ID: 32343227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promiscuous G-Protein-Coupled Receptor Inhibition of Transient Receptor Potential Melastatin 3 Ion Channels by Gβγ Subunits.
    Alkhatib O; da Costa R; Gentry C; Quallo T; Bevan S; Andersson DA
    J Neurosci; 2019 Oct; 39(40):7840-7852. PubMed ID: 31451581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRPM3 channel activation inhibits contraction of the isolated human ureter via CGRP released from sensory nerves.
    Liu J; Zhao M; Chen Z; Xu Y; Guo L; Wang S; Li Y; Shi B; Zhang X; Jin XD
    Life Sci; 2021 Mar; 268():118967. PubMed ID: 33417951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of impaired Transient Receptor Potential Melastatin 3 ion channel activity in natural killer cells from Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis patients.
    Cabanas H; Muraki K; Balinas C; Eaton-Fitch N; Staines D; Marshall-Gradisnik S
    Mol Med; 2019 Apr; 25(1):14. PubMed ID: 31014226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Transient Receptor Potential Melastatin 3 ion channels by G-protein βγ subunits.
    Badheka D; Yudin Y; Borbiro I; Hartle CM; Yazici A; Mirshahi T; Rohacs T
    Elife; 2017 Aug; 6():. PubMed ID: 28829742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of steroid-sensitive TRPM3 channels potentiates glutamatergic transmission at cerebellar Purkinje neurons from developing rats.
    Zamudio-Bulcock PA; Everett J; Harteneck C; Valenzuela CF
    J Neurochem; 2011 Nov; 119(3):474-85. PubMed ID: 21955047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural requirements of steroidal agonists of transient receptor potential melastatin 3 (TRPM3) cation channels.
    Drews A; Mohr F; Rizun O; Wagner TF; Dembla S; Rudolph S; Lambert S; Konrad M; Philipp SE; Behrendt M; Marchais-Oberwinkler S; Covey DF; Oberwinkler J
    Br J Pharmacol; 2014 Feb; 171(4):1019-32. PubMed ID: 24251620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diclofenac, a nonsteroidal anti-inflammatory drug, is an antagonist of human TRPM3 isoforms.
    Suzuki H; Sasaki E; Nakagawa A; Muraki Y; Hatano N; Muraki K
    Pharmacol Res Perspect; 2016 Jun; 4(3):e00232. PubMed ID: 27433342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the transient receptor potential channel TRPM3 by phosphoinositides.
    Tóth BI; Konrad M; Ghosh D; Mohr F; Halaszovich CR; Leitner MG; Vriens J; Oberwinkler J; Voets T
    J Gen Physiol; 2015 Jul; 146(1):51-63. PubMed ID: 26123194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of TRPM3 by a potent synthetic ligand reveals a role in peptide release.
    Held K; Kichko T; De Clercq K; Klaassen H; Van Bree R; Vanherck JC; Marchand A; Reeh PW; Chaltin P; Voets T; Vriens J
    Proc Natl Acad Sci U S A; 2015 Mar; 112(11):E1363-72. PubMed ID: 25733887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The newest TRP channelopathy: Gain of function TRPM3 mutations cause epilepsy and intellectual disability.
    Zhao S; Rohacs T
    Channels (Austin); 2021 Dec; 15(1):386-397. PubMed ID: 33853504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Therapeutic Benefit of Low Dose Naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Role of Transient Receptor Potential Melastatin 3 Ion Channels in Pathophysiology and Treatment.
    Cabanas H; Muraki K; Eaton-Fitch N; Staines DR; Marshall-Gradisnik S
    Front Immunol; 2021; 12():687806. PubMed ID: 34326841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.